Gabapentin Dementia Lawsuit in Louisiana

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

Louisiana: 1 year prescriptive period for personal injury (La. Civ. Code art. 3492). Discovery rule (contra non valentem doctrine) applies — prescription begins when the plaintiff discovers or should have discovered the injury and its cause. Louisiana's short prescriptive period requires prompt action.

1 year from discovery of injury (prescriptive period)

Filing Venue

Where to File in Louisiana

Louisiana gabapentin cases may be filed in the Eastern District (New Orleans), Middle District (Baton Rouge), or Western District (Shreveport, Lafayette). Orleans Parish Civil District Court handles complex pharmaceutical litigation. Louisiana's civil law system applies the Louisiana Products Liability Act (LPLA, La. R.S. 9:2800.51 et seq.), which provides specific theories including unreasonably dangerous in construction, design, inadequate warning, and nonconformity to express warranty. The LPLA is the exclusive remedy for product liability claims in Louisiana. The state's 1-year prescriptive period is the shortest filing deadline nationally.

Louisiana Data

Exposure in Louisiana

Source: IQVIA / LA PDMP data

Source: Louisiana Workforce Commission / CDC occupational health data

Source: Louisiana Products Liability Act, La. R.S. 9:2800.51 et seq.

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Gabapentin Dementia Lawsuit Lawsuit Overview